News

Spatial transcriptomics may transform prostate cancer research by mapping immune cell localization and gene expression in ...
The use of stereotactic body radiotherapy (SBRT) as salvage therapy after radical prostatectomy was well tolerated, with no ...
For men who undergo a radical prostatectomy for the treatment of prostate cancer, post-surgery radiation therapy can play a ...
For men who undergo a radical prostatectomy for the treatment of prostate cancer, post-surgery radiation therapy can play a ...
Learn about the spit test that has shown promising results for detecting prostate cancer risk, proving to be more reliable ...
URO-1, a Greensboro medical device company in prostate and soft tissue cancer diagnostics, has secured a new round of equity ...
Telix Pharmaceuticals excels in radiopharmaceuticals, with strong revenue growth driven by imaging products like Illuccix.
Are Auto-Generated Organ-at-Risk Contours Good Enough in Prostate Radiotherapy?. International Journal of Medical Physics, ...
New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in both hormone-sensitive and castration-resistant patients.
Once prostate cancer no longer responds to hormonal therapy, the cancer is called castration-resistant. Find out which ...
New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in both ...